CFO’s Tech Companies to Watch: Symbiont

Symbiont is successfully applying blockchain to specific, concrete problems in the world of corporate finance.
CFO’s Tech Companies to Watch: Symbiont

[Editor’s Note: The original version of this story indicated that Symbiont’s blockchain technology was to be integrated with the state of Delaware’s systems to “enable end-to-end automation of corporate securities administration.” It also implied that Delaware corporations, to use blockchain for that purpose, would be bound to Symbiont’s technology. According to a spokesperson from Delaware’s department of state, both of those statements are incorrect.

The Delaware spokesperson says Symbiont participated in brainstorming efforts about future blockchain projects for the state, but never had a formal relationship with the department of state at any time. The state department also disputes that Symbiont helped write the legislation that recognized blockchain as an acceptable form of recordkeeping for Delaware-registered corporations.

A Better Way to Do Ecommerce

A Better Way to Do Ecommerce

Learn how Precision Medical leveraged OneWorld to cut the cost of billing in half and added $2.5M in annual revenue.

However, there is evidence that Symbiont was indeed a driving force behind the Delaware Blockchain Initiative (DBI), was involved (at some level) in crafting the language of the law in question, and was appointed by former Governor Jack Markell as the state’s technology partner for the DBI.]

We combed through websites, interviewed tech experts, and researched a host of product categories to assemble, once again, the roster of 20 companies that make up our annual “Tech Companies to Watch.” We uncovered a wide range of technologies and products that would be valuable to finance chiefs, and we also discovered a wealth of innovation going on in “traditional” finance-related tech categories.

The entirety of the list appears in the April/May 2018 edition of CFO magazine. We are revealing the first 10 companies on, one per day. Our first nine tech companies to watch were Pymetrics, PrattleTipalti, UiPathExabeam,, EmagiaAdaptive Insights, and Duo Security.


A lot of people talk about applications for blockchain like they talk about renovating their basement: the talk doesn’t result in much action. But Symbiont, a startup, is earning revenue and actually succeeding in applying blockchain to specific, concrete problems in the world of finance.

Blockchain is the much-hyped, digital distributed ledger technology that records transactions chronologically and publicly without a central administrator. It powers the cryptocurrency bitcoin, but many entrepreneurs are trying to adapt it for other business uses.

Symbiont info boxWhen one of the founders of Symbiont, CEO Mark Smith, first set out, he was looking for a technology to solve some of the market weaknesses exposed during the 2008 banking crisis. Among them were the dangers of counterparty risk.

“We were looking for a way to bring markets back to their natural state, which is decentralized and distributed,” says Smith.

After having blockchain explained to him by mathematicians, Smith realized it presented an opportunity to build “peer-to-peer markets in which you don’t have to have an intermediary and can create true transparency without counterparty risk.”

By 2014, the company was developing what Smith calls “a novel and purpose-built” proprietary blockchain and smart contracts solution for certain areas of the capital markets. (A smart contract is a computer protocol designed to digitally facilitate, verify, or enforce the negotiation or performance of a contract.) Four years later, Symbiont’s traction with blockchain applications for corporations is somewhat startling.

In August 2017, Delaware passed a law (which Symbiont says it helped write) recognizing blockchain as an acceptable form of recordkeeping for Delaware-registered corporations. They can issue shares and manage ownership records using blockchain technology.

The law will enable end-to-end automation of corporate securities administration, from inception to maturity.

Symbiont is also “on a very long roadmap” with index fund giant Vanguard Group to develop several blockchain products. The first is an effort to automate the distribution of equity index data.

When Vanguard receives information about corporate actions that requires it to rebalance its passive funds, the process requires “massive amounts of internal reconciliation, and is fraught with errors due to the use of database replication and screen scraping,” says Smith. Successful distribution with the Symbiont blockchain has already been tested for two quarters with data provider CRSP.

Finally, Symbiont, along with several partners, has tested a working solution to automate the servicing of syndicated loans.

With blockchain, in theory, a syndicated loan facility could be supported from origination to payoff. Besides involving multiple participants on a peer-to-peer basis, “a [syndicated] loan is a living instrument — cash-flow payments change from month to month, for example,” says Smith. “It’s a homerun for blockchain and smart contracts.”

Symbiont has plenty of competitors in the race to realize the promise of blockchain. They include the IBM Hyperledger project and even the bitcoin and ethereum blockchains. But many of the open-source projects, in particular, are “not ready for prime time in financial markets,” says Smith.

Indeed, Symbiont’s biggest battle may be in just getting executives to understand what blockchain is (only 3% of CFOs claim to) and to “fight misrepresentations in the media and in general.” Says Smith: “Many people way overstate what blockchain technology can do — almost like it’s a snake oil, which it’s not.”

The rash of initial coin offerings of cryptocurrencies, which Smith calls “a horrible black eye on our ecosystem,” is another obstacle.

“Now when you talk about blockchain or bitcoin, it gets lumped in with those ICOs, and we’re back to where we were in 2013, when we were trying to convince everyone that bitcoin wasn’t just for criminals.”